HDAC inhibitors induce acetylation and displacement of c-Myc from the promoter and Sp1 is freed to promote transcription of TRAIL and induction of apoptosis in primary blasts derived from AML patients (Fig. 5a).269. This evidence concerns the gene MYC and acute myeloid leukemia.